2 recruiting, 1 terminated, 1 unknown. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 1, Unknown 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow 64Cu-DOTA-ECL1i: new trials by email Literature Review of 64Cu-DOTA-ECL1i trials Research Report on 64Cu-DOTA-ECL1i
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CCR2 PET Imaging Head and Neck Squamous Cell Carcinoma 64Cu-DOTA-ECL1i - Head and Neck Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M) | Phase 2 | Recruiting | Washington University School of Medicine | 90 | 2026-10-31 | 2026-10-07 |
| Molecular Imaging of the Underlying Mechanism of Vessel Wall Inflammation Using Positron Emission Tomography (PET/CT) 64Cu-DOTA-ECL1i - Abdominal Aortic Aneurysm | Recruiting | University of Pennsylvania | 30 | 2026-04-30 | 2026-05-22 | |
| Imaging CCR2 Receptors With 64Cu-DOTA-ECL1i in Head and Neck Cancer 64Cu-DOTA-ECL1i - Head and Neck Cancer | Phase 1 | Terminated | Washington University School of Medicine | 11 | 2020-02-07 | 2024-11-19 |
| Evaluation of CCR2 in Patients Post Myocardial Infarction 64Cu-DOTA-ECL1i - Heart Diseases | Phase 1 | Unknown | Washington University School of Medicine | 90 | 2018-11-24 | 2022-11-23 |
Head and Neck Neoplasms (2) · Aortic Aneurysm (1) · Aortic Aneurysm, Abdominal (1) · Heart Diseases (1) · Neoplasm Metastasis (1) · Recurrence (1) · Squamous Cell Carcinoma of Head and Neck (1)
Washington University School of Medicine (3) · University of Pennsylvania (1)
United States (4)
Farrokh Dehdashti, M.D. (1) · Farrokh Dehdashti, MD (1) · Scott M Damrauer, MD (1)
P41EB025815 (1), R01CA311209 (1)